Loading company
Loading
Latest annual · FY2021
Millions- Total revenues
- 0
- Operating income
- (174)
- Net income
- (173)
Forma Therapeutics Holdings, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2022-03-01 · proof | |
| Operating income | -$174 million | -$124.2 million | 10-K 2022-03-01 · proof | |
| Net income | -$173 million | -$70.4 million | 10-K 2022-03-01 · proof | |
| Cash from operating activities | -$149.8 million | -$95.4 million | 10-K 2022-03-01 · proof | |
| Free cash flow | -$154 million | -$95.7 million | 10-K 2022-03-01 · proof | |
| Total assets | $561.1 million | $681 million | -17.6% | 10-K 2022-03-01 · proof |
| Total liabilities | $62.7 million | $32.7 million | +91.6% | 10-K 2022-03-01 · proof |
| Cash and cash equivalents | $77.4 million | $282.7 million | -72.6% | 10-K 2022-03-01 · proof |
- What was Forma Therapeutics Holdings, Inc.'s revenue in fiscal 2021?
- Forma Therapeutics Holdings, Inc. reported revenue of $0 for fiscal 2021 (the year ended Dec 31, 2021), against $0 the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What was Forma Therapeutics Holdings, Inc.'s operating income in fiscal 2021?
- Forma Therapeutics Holdings, Inc. reported operating income of -$174 million for fiscal 2021 (the year ended Dec 31, 2021), against -$124.2 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What was Forma Therapeutics Holdings, Inc.'s net income in fiscal 2021?
- Forma Therapeutics Holdings, Inc. reported net income of -$173 million for fiscal 2021 (the year ended Dec 31, 2021), against -$70.4 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What was Forma Therapeutics Holdings, Inc.'s cash from operating activities in fiscal 2021?
- Forma Therapeutics Holdings, Inc. reported cash from operating activities of -$149.8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$95.4 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What was Forma Therapeutics Holdings, Inc.'s free cash flow in fiscal 2021?
- Forma Therapeutics Holdings, Inc. reported free cash flow of -$154 million for fiscal 2021 (the year ended Dec 31, 2021), against -$95.7 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What are Forma Therapeutics Holdings, Inc.'s total assets?
- As of Dec 31, 2021, Forma Therapeutics Holdings, Inc. reported total assets of $561.1 million, against $681 million a year earlier (-17.6%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What are Forma Therapeutics Holdings, Inc.'s total liabilities?
- As of Dec 31, 2021, Forma Therapeutics Holdings, Inc. reported total liabilities of $62.7 million, against $32.7 million a year earlier (+91.6%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What are Forma Therapeutics Holdings, Inc.'s cash and cash equivalents?
- As of Dec 31, 2021, Forma Therapeutics Holdings, Inc. reported cash and cash equivalents of $77.4 million, against $282.7 million a year earlier (-72.6%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1538927&period_type=annual&limit=5"Information only, not investment advice.